Showing results (31-40 of 56) with videos related to

Sort By:
Pageof 6
International Journal of Cancer|September 16, 2015
Patients aged over 75 years enrolled in Phase I clinical trials: the Gustave Roussy experienceCarole Helissey, Pamela Biondani, Florian Roquet, et al.
AIDS (London, England)|July 2, 2019
Immunotherapy for cancer in people living with HIV: safety with an efficacy signal from the series in real life experienceJean-Philippe Spano, Marianne Veyri, Aurélien Gobert, et al.
JMIR Cancer|December 12, 2024
Correlation Between Electronic Patient-Reported Outcomes and Biological Markers of Key Parameters in Acute Radiation Cystitis Among Patients With Prostate Cancer (RABBIO): Prospective Observational StudyCarole Helissey, Sophie Cavallero, Nathalie Guitard, et al.
The Oncologist|December 31, 2025
Home-based supervised exercise on metastatic cancer patients receiving oral targeted therapy: the AFSOS-Unicancer QUALIOR randomized phase 2 studyFlorence Joly, Claudia Lefeuvre-Plesse, Emilie Charton, et al.
BMC Cancer|October 10, 2020
Feasibility and efficacy of a supervised home-based physical exercise program for metastatic cancer patients receiving oral targeted therapy: study protocol for the phase II/III - UNICANCER SdS 01 QUALIOR trialFlorence Joly, Claudia Lefeuvre-Plesse, Claire Garnier-Tixidre, et al.
Cancer Medicine|October 6, 2020
Evaluation of medical practices in oncology in the context of the COVID-19 pandemic in France: Physicians' point of view: the PRATICOVID studyCarole Helissey, Anatole Cessot, Laurys Boudin, et al.
Cancers|April 3, 2021
Does Very Poor Performance Status Systematically Preclude Single Agent Anti-PD-1 Immunotherapy? A Multicenter Study of 35 Consecutive PatientsValérie Gounant, Michael Duruisseaux, Ghassen Soussi, et al.
Bulletin Du Cancer|April 16, 2021
How did we take care of our older cancer patients during the first COVID-19 wave? The French experienceCarole Helissey, Djamel Ghebriou, Anatole Cessot, et al.
Anti-Cancer Drugs|January 9, 2015
Safety of spinal radiotherapy in metastatic cancer patients receiving bevacizumab therapy: a bi-institutional case seriesRodrigue Mbagui, Julien Langrand-Escure, Pierre Annede, et al.
Age and Ageing|February 12, 2024
Disentangling the reasons why older adults do not readily participate in cancer trials: a socio-epidemiological mixed methods approachMeoïn Hagège, Michaël Bringuier, Claudia Martinez-Tapia, et al.
Pageof 6